Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c16d2144a81bfa32a665dca1e93c3d37 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2013-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25c0084f2d2eda16cb61b9850ade1c15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51dd957ab66e3e6e7a98339a9620cdd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78b651875d29c87e5c494e95806a1245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9d50e84f1677b2c4e38c12ac52fd45b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a598ca0917cf3a6a97b48bbd9efbb98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00323787592e7b3cdd579b2c47fcca4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_726cc6c9cbc78f2b2b710b85a707da0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b0775a5a57e35fb6beb47aae88b3cf9 |
publicationDate |
2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20150063728-A |
titleOfInvention |
Anti-VEGF-C/anti-Ang2 bispecific antibody |
abstract |
There is provided a pharmaceutical composition for preventing and / or treating an anti-VEGF-C / anti-Ang2 bispecific antibody, and Ang2 and / or VEGF-C related diseases comprising the same. |
priorityDate |
2013-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |